Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03884608 · ClinicalTrials.gov registry record
Analysis of Both Sex and Device Specific Factors on Outcomes in Patients with Non-Ischemic Cardiomyopathy
A clinical trial, sponsored by Biotronik.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT03884608 is a clinical trial that has completed, run by Biotronik. The registered enrollment target is 1,000 participants.
The verdict
NCT03884608 has completed, sponsored by Biotronik.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
The purpose of this registry is to prospectively assess outcomes of device-treated ventricular tachyarrhythmias and all-cause mortality in non-ischemic cardiomyopathy patients indicated for ICD or CRT-D implantation for the primary prevention of sudden cardiac death. Differences in outcomes will be evaluated by sex and by device type.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2019-05-09 |
| Est. Completion | 2024-11-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03884608
The ClinicalTrials.gov registry entry for NCT03884608 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biotronik, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03884608 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03884608 about?
NCT03884608 is a clinical study titled "Analysis of Both Sex and Device Specific Factors on Outcomes in Patients with Non-Ischemic Cardiomyopathy". The purpose of this registry is to prospectively assess outcomes of device-treated ventricular tachyarrhythmias and all-cause mortality in non-ischemic cardiomyopathy patients indicated for ICD or CRT-D implantation for the primary prevention of sudden cardiac death. Differences in outcomes will be ...
What is the current status of trial NCT03884608?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2019-05-09. Estimated completion is 2024-11-19.
Who is sponsoring clinical trial NCT03884608?
This trial is sponsored by Biotronik, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.